A transformative gift to expand research and breakthrough therapies, an upcoming conference on managing neuroendocrine tumors, FDA approval of Imetelstat for patients with anemia from myelodysplastic syndromes and a researcher advocating for making bereavement care a public health priority are all included in this month’s tip sheet from Sylvester Comprehensive Cancer Center.
Tag: Kenneth C. Griffin
University of Miami’s Sylvester Comprehensive Cancer Center Announces Transformational Gift From Kenneth C. Griffin
The University of Miami today announced a transformational $50 million gift from Kenneth C. Griffin, Founder and Chief Executive Officer of Citadel and Founder of Griffin Catalyst, to Sylvester Comprehensive Cancer Center, part of the University of Miami Health System and the Miller School of Medicine.